Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page
- CheckyesterdayChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check66 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with the removal of the funding-status notice. These are administrative updates that do not alter the study details or results presented on the page.SummaryDifference0.3%

- Check73 days agoChange DetectedAdded a notice about a lapse in government funding and NIH operating status with a link to opm.gov and cc.nih.gov. Updated page version to v3.4.1.SummaryDifference0.3%

- Check80 days agoChange DetectedUI/text updates include adding a glossary toggle and updating several labels (QC criteria wording and FEAR Act data) along with the revision/version to v3.4.0. No core study content, data, or essential functionality were altered.SummaryDifference0.1%

Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.